Literature DB >> 7225303

Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding.

S K Smith, M H Abel, R W Kelly, D T Baird.   

Abstract

The endogenous concentrations of prostaglandins F2 alpha (PGF 2 alpha) and E (PGE) were measured during the luteal phase of the menstrual cycle in the endometrium from 14 women with unexplained menorrhagia (measured menstrual blood loss in excess of 50 ml) and 15 women with normal menses (blood loss 50 ml or less). Although there was no significant difference in the PGF 2 alpha/PGE ratio between the two groups, this ratio was significantly lower in the endometrium from eight of the women whose blood loss exceeded 90 ml (p less than 0.05). There was a significant inverse correlation between the PGF 2 alpha/PGE ratio and blood loss (r = 0.36, p less than 0.025). The synthetic capacity of the endometrium was assessed by incubation of the tissue with 14C arachidonic acid. Endometria from nine women with unexplained menorrhagia synthesized more PGE2 than PGF 2 alpha, whereas the converse was true with 11 control endometria. Consequently the PGF2 alpha/PGE2 ratio was significantly reduced in the former group (p less than 0.025). Oestradiol-17 beta (200 microM) and to a greater extent 2 hydroxy oestradiol (200 microM) increased the total prostaglandin synthesis by the endometria, but did not significantly alter the PGF2 alpha/PGE2 ratio. These results suggest that excessive blood loss may be associated with a shift in the endometrial conversion of prostaglandin endoperoxide from PGF2 alpha to PGE2.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7225303     DOI: 10.1111/j.1471-0528.1981.tb01009.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  29 in total

Review 1.  Fortnightly review. Medical management of menorrhagia.

Authors:  A Prentice
Journal:  BMJ       Date:  1999-11-20

2.  Dysfunctional uterine bleeding.

Authors:  R F Casper
Journal:  Can Fam Physician       Date:  1983-04       Impact factor: 3.275

3.  Medical management of menorrhagia.

Authors:  A Prentice
Journal:  West J Med       Date:  2000-04

4.  Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.

Authors:  Magdalena Bofill Rodriguez; Anne Lethaby; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2019-09-19

5.  Haemostatic mechanism in the endometrium: role of cyclo-oxygenase products and coagulation factors.

Authors:  T J Gelety; G Chaudhuri
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

6.  Prostaglandins and menstrual disorders.

Authors:  M G Elder
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-10

Review 7.  Dysfunctional uterine bleeding.

Authors:  B H Chen; L C Giudice
Journal:  West J Med       Date:  1998-11

8.  Management of dysfunctional uterine bleeding.

Authors:  C M Farquhar
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

Review 9.  Menorrhagia. Current drug treatment concepts.

Authors:  M A van Eijkeren; G C Christiaens; P C Scholten; J J Sixma
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

10.  EP2 receptor mediated cAMP release is augmented by PGF 2 alpha activation of the FP receptor via the calcium-calmodulin pathway.

Authors:  A B Abera; K J Sales; R D Catalano; A A Katz; H N Jabbour
Journal:  Cell Signal       Date:  2009-09-25       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.